Cargando…
Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain
BACKGROUND: Mechanisms driving cancer-induced bone pain are poorly understood. A central factor implicated to be a key player in the process of tumorigenesis, osteoclastogenesis and nociception is p38 MAPK. We determined the role of p38 MAPK in a mouse model of breast cancer induced bone pain in whi...
Autores principales: | Sukhtankar, Devki, Okun, Alec, Chandramouli, Anupama, Nelson, Mark A, Vanderah, Todd W, Cress, Anne E, Porreca, Frank, King, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212934/ https://www.ncbi.nlm.nih.gov/pubmed/22014040 http://dx.doi.org/10.1186/1744-8069-7-81 |
Ejemplares similares
-
Behavioral and neurochemical analysis of ongoing bone cancer pain in rats
por: Remeniuk, Bethany, et al.
Publicado: (2015) -
Use of Animal Models in Understanding Cancer-induced Bone Pain
por: Slosky, Lauren M, et al.
Publicado: (2015) -
Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents
por: Okun, Alec, et al.
Publicado: (2011) -
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain
por: Forte, Brittany L., et al.
Publicado: (2016) -
The Role of Alpha 6 Integrin in Prostate Cancer Migration and Bone Pain in a Novel Xenograft Model
por: King, Tamara E., et al.
Publicado: (2008)